help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deplewski, D.
Right arrow Articles by Rosenfield, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deplewski, D.
Right arrow Articles by Rosenfield, R. L.
Endocrinology Vol. 138, No. 10 4416-4420
Copyright © 1997 by The Endocrine Society


ARTICLES

Preputial Sebocyte 5{alpha}-Reductase Isoform Specificity1

Dianne Deplewski, Shutsung Liao and Robert L. Rosenfield

The University of Chicago, Pritzker School of Medicine, Departments of Pediatrics (D.D., R.L.R.), Medicine (R.L.R.), and Biochemistry and Molecular Biology (S.L.), Chicago, Illinois 60637-1470

Address all correspondence and requests for reprints to: Robert L. Rosenfield, M.D., The University of Chicago, Pritzker School of Medicine, Department of Pediatrics and Children’s Research Foundation, 5841 South Maryland Avenue (MC-5053), Chicago, Illinois 60637-1470.


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
We determined whether the 5{alpha}-reductase (5{alpha}-R) isozyme specificity in rat preputial sebocytes is in accordance with that of sebaceous glands (type 1 isoform) or with that of other genital tract androgen-dependent organs (type 2). Immunostaining indicated expression of type 1 5{alpha}-R in preputial epithelial cells in the gland as well as in culture. Northern blots and ribonuclease protection assays both showed the presence of the type 1 isozyme in preputial sebocytes, with little if any expression of the type 2 messenger RNA. Ribonuclease protection assay demonstrated that both homogenized preputial gland and freshly dispersed preputial cells express 2-fold more 5{alpha}-R type 1 messenger RNA than does skin and 7-fold more than cultured preputial cells. Since cultured preputial cells do not fully differentiate in monolayer culture, these findings suggest that 5{alpha}-R is increasingly expressed as sebaceous cells differentiate. The predominance of the type 1 isoform in preputial sebocytes is important because it indicates programming by a skin- and sebocyte-specific signal in the midst of the genital tract where the type 2 isoform otherwise predominates.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
THE PREPUTIAL gland is an androgen target tissue (1, 2, 3) composed primarily of sebocytes, which are specialized epithelial cells that resemble human sebaceous cells in many ways (4, 5, 6). As with other sebaceous glands, androgen has been found to stimulate preputial gland sebocytes to grow and develop (7, 8). Preputial gland sebocytes express androgen receptor, and this expression increases with sebocyte maturation (9). The preputial glands of rats are an attractive model in which to study sebaceous cell differentiation because they are easy to isolate, and single cell suspensions can be prepared for primary cell culture (10).

5{alpha}-Reductase (5{alpha}-R) is important in androgen action as it converts testosterone, the major circulating androgen, to the more potent androgen 5{alpha}-dihydrotestosterone (DHT) (11, 12, 13, 14). Excessive DHT formation has been implicated in the pathogenesis of acne vulgaris (15, 16), suggesting that activity of 5{alpha}-R may play an important role in sebaceous cell growth and differentiation. Two forms of 5{alpha}-R exist, which are differentially expressed in various tissues, likely as a result of their respective promoters. They have different pH optima and sensitivity to inhibitors. The two isozymes are approximately 46% identical in sequence, have similar gene structures, are both hydrophobic, and share similar substrate preferences (11, 12). The type 1 gene encodes a 255-amino acid protein that is 60% homologous to the human protein (11, 17). It has a neutral to basic pH optimum and is more sensitive to finasteride than its human counterpart because of a specific four-amino acid segment in the amino terminus, which may form a portion of the substrate-binding domain (18). The type 2 isozyme has been shown to be 254 amino acids in length and to have an acidic pH optimum (11).

The type 1 isozyme has been shown in the rat to be the predominant isozyme expressed in the liver, ovary, and many somatic tissues, whereas the androgen target tissues of the genital tract, such as the epididymis and vas deferens, have been found to express mainly the type 2 isozyme (11). Because of these differences in tissue distribution, as well as substrate affinities, it has been postulated that the type 1 isozyme plays a catabolic role (such as inactivating testosterone in the peripheral tissues), and the type 2 isozyme plays an anabolic role in steroid hormone metabolism (11, 19). However, this is clearly an oversimplification. For example, in humans the type 1 isozyme has been found to be the major form of 5{alpha}-R in the sebaceous cells of the scalp (13, 20, 21, 22). To further understand sebaceous gland development, we have determined whether 5{alpha}-R isozyme expression in the sebocytes of the rat preputial gland is in accordance with that reported for other androgen-dependent genital tract organs or with other sebaceous cells.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Tissues and cells
Tissue samples from male (preputial gland, epididymis, and prostate), and female (preputial gland, ovary, and liver) young adult Sprague-Dawley rats were minced in 4 C PBS, and dorsal skin (from males and females) was snap frozen in liquid nitrogen and powdered on dry ice. Homogenates were made with a polytron in 4 M guanidinium thiocyanate, 25 mM Na-Citrate, 0.5% sarcosyl, and 0.1 M 2-mercaptoethanol (23). Epithelial cell suspensions were prepared from the preputial glands and shaved dorsal skin as previously reported (6). Cell culture was carried out as previously reported on a 3T3-J2 mitomycin-C treated feeder layer in an epithelial cell culture medium containing 10% FCS (6). Epithelial cells were harvested after incubation with EDTA and trypsin.

Immunostaining
Rat preputial glands were frozen in liquid nitrogen, sectioned on a cryostat, and fixed to gelatin-coated slides using a paraformaldehyde-picric acid fixative. Cells grown on plastic slides or cell smears were fixed in methanol for 20 min at -20 C. The sections were probed with control Igs purified from serum of nonimmunized rabbits and a rabbit antirat polyclonal antibody to a C-terminal peptide (amino acids 238–254) of rat 5{alpha}-R type 1 (24). Immunoblotting with the peptide antibody detected a single component in rat liver macrophages of the appropriate size for 5{alpha}-R type 1 (24). A biotin-streptavidin-conjugated peroxidase staining system was used (Zymed, San Francisco, CA). The sections were counterstained with hematoxylin. To demonstrate specific immunoreactivity of the 5{alpha}-R type 1 antibody, immunostaining was repeated after preincubation of the antibody with the peptide antigen.

DNA probes
Rat 5{alpha}-R type 1 complementary DNA (cDNA) is an 834-bp fragment inserted into the transcription vector pBluescript SK at the EcoRI site of the polylinker (24). Rat 5{alpha}-R type 2 cDNA was obtained from Dr. D. W. Russell (University of Texas, Dallas, TX) as a 1786-bp fragment inserted in the EcoRI site of the polylinker of pBluescript SK. Glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) cDNA consisted of a 1270-bp fragment inserted into the PstI site in the polylinker of the transcription vector pGEM 3Z (25). The plasmids containing the 5{alpha}-R type 1 and 2 were digested with EcoRI, and the 834-bp fragment of 5{alpha}-R type 1 and the 1786-bp fragment of type 2 were isolated from agarose gels. A 500-bp fragment of GAPDH was similarly isolated after digestion with BglI. Random labeled DNA probes were constructed using random hexanucleotides and the Klenow fragment of DNA polymerase I in the presence of 32P-labeled deoxycytidine triphosphate and three other nucleotide triphosphates (26).

Riboprobes
The vectors containing the 5{alpha}-R cDNAs were cut with PST I and re-ligated. The 216-bp riboprobe for type 1 and the 199-bp riboprobe for type 2 were made by linearizing the respective plasmids with the restriction enzyme HindIII and then using T3 RNA polymerase in the presence of {alpha}-32P-labeled uridine triphosphate (UTP) and three other nucleotide triphosphates (26). A 109-bp internal control probe was created by linearizing pT7 18S ribosomal RNA (rRNA) (Ambion, Austin, TX) and transcribing with T7 RNA polymerase as above.

Northern blot analysis
Total RNA (10 µg per sample) isolated by the guanidinium thiocyanate method (23) was separated on a formaldehyde-containing agarose gel, transferred to a Duralon UV membrane (Stratagene, La Jolla, CA ) by capillary elution, prehybridized, and then hybridized with random labeled DNA probes at 42 C for 16–20 h. The filter was subsequently washed and exposed to x-ray film (26). GAPDH was used as an internal loading control.

RNAse protection assay
Total RNA (10 µg) was hybridized to 32P-labeled antisense RNA probes specific for 5{alpha}-R type 1 and 2. An antisense RNA probe to 18S rRNA was used to normalize data for variations in the amount of RNA in each reaction. Unprotected RNA was digested with RNase A and T1 for 30 min at 37 C. The protected RNA hybrids were subsequently separated on a 5% polyacrylamide/8 M urea gel (27). The gel was dried and exposed to x-ray film, and the bands were quantified using an AMBIS (San Diego, CA) image acquisition and analysis system.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Immunohistochemistry demonstrated the type 1 iso-zyme in the basal immature cells of the preputial gland, as well as in the most mature sebocytes in the center of the preputial acini. 5{alpha}-R expression was found predominantly in the cytoplasm of the preputial cells, suggesting this as the primary site of DHT formation (Fig. 1AGo). Immunocytochemistry of dispersed single cell suspensions and primary cell culture likewise demonstrated expression of 5{alpha}-R type 1 mainly in the cytoplasm of both preputial and epidermal cells, with little if any expression in the nuclei (Fig. 1Go, B and 1C). Incubation with a nonspecific control antibody showed no staining (Fig. 1Go, A–C). Preincubation of the type 1 antibody with the peptide antigen completely abolished the staining (results not shown, but similar to control antibody).



View larger version (152K):
[in this window]
[in a new window]
 
Figure 1. A, Immunohistochemistry of a sectioned preputial gland using either a rabbit antirat polyclonal antibody to a C-terminal peptide of 5{alpha}-R type 1 (left panel), or a control antibody (right panel), in a biotin-streptavidin- conjugated peroxidase staining system, whereby the bound antibody stains (dark). 5{alpha}-R is present in preputial acinar cells, mainly in the cytoplasm, at all stages of differentiation. B, Immunocytochemistry of dispersed single cell suspensions of preputial cells (left panel), and of epidermal cells (right panel). 5{alpha}-R staining is marked in the preputial and epidermal cell cytoplasm, with little if any staining in the nucleus. The center panel shows preputial cells incubated with a control antibody. C, Immunocytochemistry of preputial (left panel) and epidermal (right panel) cells in primary culture. Both cell types show expression of the type 1 isozyme within the cytoplasm. Preputial cells incubated with a control antibody (center panel) showed no staining.

 
Northern blots of total RNA isolated from homogenized tissues showed type 1 mRNA in preputial RNA from both male and female rats, as well as in skin at a lower level of expression than in preputial sebocytes. The type 1 isozyme was also expressed in liver, ovary, and prostate. The type 2 mRNA was detected in prostate and epididymis. A faint band at 2.4 kb may represent a low amount of type 2 mRNA expression in preputial sebocytes or nonspecific binding (Fig. 2Go).



View larger version (46K):
[in this window]
[in a new window]
 
Figure 2. Northern blot analysis. Autoradiograph of 5{alpha}-R type 1 and type 2 in male (m) and female (f) preputial gland and skin, epididymis (epid), ovary (ov), liver (liv), and prostate (pr). Type 1 mRNA (2.4 kb) was detected in preputial RNA from both males and females and was more abundant in preputial than in skin RNA, second only to liver. It was detected to some extent in all tissues. Type 2 mRNA (2.4 kb and 4.4 kb) was detected in epididymis and prostate. The faint band in preputial RNA may represent a low amount of expression or nonspecific binding.

 
RNase protection assays demonstrated only the type 1 isozyme in preputial sebocytes and skin (Fig. 3Go). Freshly isolated preputial cells expressed amounts of the type 1 isozyme similar to homogenized preputial gland (Fig. 4AGo) and 2-fold more than skin (P < 0.01; Table 1Go) (Figs. 3Go and 4AGo). Type 1 mRNA abundance averaged 7-fold greater in freshly isolated preputial cells than in cultured preputial cells (P < 0.01; Table 1Go) (Fig. 4BGo). In contrast, both cultured and freshly isolated epidermal cells expressed similar amounts of type 1 mRNA (Table 1Go and Fig. 4BGo).



View larger version (44K):
[in this window]
[in a new window]
 
Figure 3. RNase protection assay. Autoradiographs of 5{alpha}-R type 1 and type 2 in homogenized preputial gland (Pp), prostate (pr), dorsal skin (sk), liver (liv), epididymis (epi), and ovary (ov). 5{alpha}-R type 1 mRNA (216 bp) was detected in preputial gland (second only to liver) and to a lesser extent in skin, ovary, and epididymis. 5{alpha}-R type 2 (199 bp) was detected in epididymis and faintly in prostate. No expression of the type 2 isozyme was found in the preputial gland or skin.

 


View larger version (33K):
[in this window]
[in a new window]
 
Figure 4. RNase protection assay/autoradiographs of 5{alpha}-R type 1. A, Expression of type I mRNA is similar in homogenized (h) and freshly isolated cells (f). Liver RNA served as a positive control for preputial gland (Pp), dorsal skin (sk), prostate (pr), liver (liv), and epididymis (epi). B, Type 1 mRNA expression was greater in freshly isolated preputial cells than in cultured (cx) preputial cells. Freshly isolated skin and cultured skin expressed similar levels of the type 1 isozyme and approximately twice that of cultured preputial cells.

 

View this table:
[in this window]
[in a new window]
 
Table 1. 5{alpha}-Reductase type 1 gene expression in preputial sebocytes and epidermal cells1

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
We have demonstrated by immunostaining, Northern analysis, and RNase protection assay that the type 1 isozyme is the predominant form of 5{alpha}-R present in rat preputial sebocytes and skin. We also found the type 1 isozyme to be expressed in the ovary and liver of the female rat as has been previously reported (11, 28). This high amount of type 1 enzyme expression present in the liver likely plays a catabolic role in terms of inactivating testosterone and other steroids. The presence of the type 1 isozyme in the ovary may also serve a catabolic role (19). We demonstrated the type 2 isozyme in prostate on both Northern blot and RNase protection assay, although at low levels; previous studies have augmented the expression of this isozyme in the regenerating prostate, after castration and pharmacological testosterone treatment (11, 29).

These data signify that sebocyte 5{alpha}-R isozyme expression is programmed by a skin-specific signal rather than a genital tract signal, which is consistent with the embryologic origin of sebaceous glands as down-growths from embryonic skin epithelium (30, 31). These results are important because the preputial gland is an androgen target gland in the midst of the genital tract where the type 2 isozyme otherwise predominates. Although we only found expression of the type 1 isozyme, it is possible that the type 2 isozyme is expressed at a different time point in development, as has been found in human skin at various ages (20).

Our results indicate that the expression of 5{alpha}-R mRNA is less in cultured preputial cells than in freshly isolated cells. Since cells grown in this monolayer culture system do not mature to the point of developing fused lipid droplets (10), our results suggest that type 1 5{alpha}-R expression, like androgen receptor gene expression (9), is low before the stage at which lipogenesis occurs and thus imply a role for 5{alpha}-R and DHT in augmenting lipogenesis in the later stages of sebocyte maturation.


    Acknowledgments
 
We thank Richard A. Hiipakka and John Kokontis for their excellent technical advice.


    Footnotes
 
1 This research was supported in part by USPHS Grants HD-06308 (to R.L.R.), DK-41670 (to S.L.), and T32 DK-07011 (to D.D.), and a grant from Eli Lilly Pharmaceuticals (to D.D.). Back

Received March 7, 1997.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Huggins C, Parson F, Jensen E 1955 Promotion and growth of preputial glands by steroids and the pituitary growth hormone. Endocrinology 57:25–52
  2. Sherins R, Bardin C 1971 Preputial gland growth and protein synthesis in the androgen-insensitive male pseudohermaphroditic rat. Endocrinology 89:835–841[Medline]
  3. Ebling FJ, Ebling E, Randall V, Skinner J 1975 The effects of hypophysectomy and of bovine growth hormone on the responses to testosterone of prostate, preputial, harderian and lachrymal glands and of brown adipose tissue in the rat. J Endocrinol 66:401–406[Abstract/Free Full Text]
  4. Potter JE, Prutkin L, Wheatley VR 1979 Sebaceous gland differentiation I. Separation, morphology and lipogenesis of isolated cells from the mouse preputial gland tumor. J Invest Dermatol 72:120–128[CrossRef][Medline]
  5. Mednieks MI, Laurent SJ, Hand AR, Rosenfield RL 1991 Cyclic AMP-receptor protein activity in rat preputial cells. J Invest Dermatol 97:517–523[CrossRef][Medline]
  6. Laurent SJ, Mednieks MI, Rosenfield RL 1992 Growth of sebaceous cells in monolayer culture. In Vitro Cell Dev Biol 28A:83–89
  7. Ebling FJ 1973 The effects of cyproterone acetate and oestradiol upon testosterone stimulated sebaceous activity in the rat. Acta Endocrinol (Copenh) 72:361–365[Abstract/Free Full Text]
  8. Mesquita-Guimaraes J, Coimbra A 1981 The effect of sexual hormones on the lipid and proteinaceous secretion of the rat preputial sebaceous gland. Arch Dermatol 270:325–331
  9. Miyake K, Ciletti N, Liao S, Rosenfield RL 1994 Androgen receptor expression in the preputial gland and its sebocytes. J Invest Dermatol 103:721–725[CrossRef][Medline]
  10. Rosenfield RL 1996 Preputial cell culture as a model system to study sebocyte development. In: Van Neste D, Randall V (eds) Hair Research for the Next Millenium. Elsevier Science BV, Amsterdam, pp 375–379
  11. Normington K, Russell DW 1992 Tissue distribution and kinetic characteristics of rat steroid 5{alpha}-reductase isozymes. J Biol Chem 267:19548–19554[Abstract/Free Full Text]
  12. Wilson JD, Griffin JE, Russell DW 1993 Steroid 5{alpha}-reductase deficiency. Endocr Rev 14:577–592[CrossRef][Medline]
  13. Andersson S, Chan HK, Einstein M, Geissler WM, Patel S 1993 The molecular genetics of steroid 5{alpha}-reductase. J Endocrinol 139[Suppl]:17
  14. Russell DW, Berman DM, Bryant JT, Cala KM, Davis DL, Landrum CP, Prihoda JS, Silver SI, Thigpen AE, Wigley WC 1994 The molecular genetics of steroid 5{alpha}-reductases. Recent Prog Horm Res 49:275–284
  15. Sansone G, Reisner RM 1971 Differential rates of conversion of testosterone to dihydrotestosterone in acne and in normal human skin. J Invest Dermatol 56:366–372[CrossRef][Medline]
  16. Dijkstra AC, Goos CM, Cunliffe WJ, Sultan C, Vermorken AJM 1987 Is increased 5{alpha}-reductase activity a primary phenomenon in androgen-dependent skin disorders? J Invest Dermatol 89:87–92[CrossRef][Medline]
  17. Anderson S, Russell DW 1990 Structural and biochemical properties of cloned and expressed human and rat steroid 5{alpha}-reductases. Proc Natl Acad Sci USA 87:3640–3644[Abstract/Free Full Text]
  18. Thigpen AE, Russell DW 1992 Four amino acid segment in steroid 5{alpha}-reductase 1 confers sensitivity to finasteride, a competitive inhibitor. J Biol Chem 267:8577–8583[Abstract/Free Full Text]
  19. Mahendroo MS, Cala KM, Landrum CP, Russell DW 1997 Fetal death in mice lacking 5{alpha}-reductase type 1 caused by estrogen excess. Mol Endocrinol 11:917–927[Abstract/Free Full Text]
  20. Thigpen AE, Silver RI, Guileyardo JM, Casey ML, McConnell JD, Russell DW 1993 Tissue distribution and ontogeny of steroid 5{alpha}-reductase isozyme expression. J Clin Invest 92:903–910
  21. Dallob AL, Sadick NS, Unger W, Lippert S, Geissler LA, Gregoire SL, Nguyen HH, Moore EC, Tanaka WK 1994 The effect of finasteride, a 5{alpha}-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness. J Clin Endocrinol Metab 79:703–706[Abstract]
  22. Harris G, Azzolina B, Baginsky W, Cimis G, Rasmusson GH, Tolman RL, Raetz CRH, Ellsworth K 1992 Identification and selective inhibition of an isozyme of steroid 5{alpha}-reductase in human scalp. Proc Natl Acad Sci USA 89:10787–10791[Abstract/Free Full Text]
  23. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Biochemistry 162:156–159
  24. Hiipakka RA, Wang M, Bloss T, Ito K, Liao S 1993 Expression of 5{alpha}-reductase in bacteria as a trp E fusion protein and its use in the production of antibodies for immunocytochemical localization of 5{alpha}-reductase. J Steroid Biochem Mol Biol 45:539–548[CrossRef][Medline]
  25. Fort P, Marty L, Piechaczyk M, Sabrouty SE, Dani C, Jeanteur P, Blanchard JM 1985 Various rat adult tissues express only one major mRNA species from the glyceradehyde-3-phosphate dehydrogenase multigenic family. Nucleic Acids Res 13:1431–1442[Abstract/Free Full Text]
  26. Sambrook J, Fritsch E, Maniatis T(eds) 1989 Molecular Cloning, ed 2. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
  27. Zinn K, DiMaio D, Maniatis T 1983 Identification of two distinct regulatory regions adjacent to the human ß-interferon gene. Cell 34:865–879[CrossRef][Medline]
  28. Andersson S, Bishop RW, Russell DW 1989 Expression cloning and regulation of steroid 5{alpha}-reductase, an enzyme essential for male sexual differentiation. J Biol Chem 264:16249–16255[Abstract/Free Full Text]
  29. Berman DM, Russell DW 1993 Cell-type-specific expression of rat steroid 5{alpha}-reductase isozymes. Proc Natl Acad Sci USA 90:9359–9363[Abstract/Free Full Text]
  30. Hardy MH 1992 The secret life of the hair follicle. Trends Genet 8:55–61[Medline]
  31. Holbrook KA, Smith LT, Kaplan ED, Minami SA, Hebert GP, Underwood RA 1993 Expression of morphogens during human follicle development in vivo and a model for studying follicle morphogenesis in vitro. J Invest Dermatol 101:39S–49S[CrossRef]



This article has been cited by other articles:


Home page
Endocr. Rev.Home page
D. Deplewski and R. L. Rosenfield
Role of Hormones in Pilosebaceous Unit Development
Endocr. Rev., August 1, 2000; 21(4): 363 - 392.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deplewski, D.
Right arrow Articles by Rosenfield, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deplewski, D.
Right arrow Articles by Rosenfield, R. L.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals